NCT02927886

Brief Summary

The objective of the study is to document the clinical efficacy and complications of endoscopic pyloromyotomy in patients with refractory gastroparesis (diabetic, post-operative and idiopathic), compared to Botulinic toxin injection intra-pyloric the results of which are close to the placebo.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2016

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 7, 2016

Completed
25 days until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

October 18, 2016

Status Verified

October 1, 2016

Enrollment Period

2.8 years

First QC Date

October 6, 2016

Last Update Submit

October 17, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gastroparesis Cardinal Symptom Index score calculation

    Up to 3 months

Study Arms (2)

Per-oral Endoscopy Pyloromyotomy (G-POEM)

EXPERIMENTAL
Procedure: Per-oral endoscopy pyloromyotomy

Intrapyloric injection of botulinum toxin

PLACEBO COMPARATOR
Procedure: Intrapyloric injection of Botulinum toxin

Interventions

Also known as: G-POEM
Per-oral Endoscopy Pyloromyotomy (G-POEM)
Intrapyloric injection of botulinum toxin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 18 years.
  • Presenting a clinical refractory gastroparesis for\> 1 year, that is to say whose functional nonspecific symptoms persisting despite medical therapy (prokinetic) optimal.
  • No history of gastric surgery (partial gastrectomy Sleeve gastrectomy, ...) or esophageal surgery
  • Not having endoscopic gastric lesions (ulcers antro-pyloric cancer).
  • Having no indication against anesthetic.
  • Having consented to participate in the study.
  • Affiliated with a social security scheme (beneficiary or assignee).

You may not qualify if:

  • Minors.
  • Pregnant or breastfeeding
  • Having an anesthetic against indication.
  • Scan the normal gastric emptying
  • Under curative dose anticoagulants whose suspension is inappropriate.
  • Under dual anti-platelet aggregation whose suspension is inappropriate.
  • Being unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastro-entérologie, Hôpital Nord ,Assistance Publique Hôpitaux de Marseille

Marseille, 13015, France

Location

MeSH Terms

Conditions

Gastroparesis

Interventions

Pyloromyotomy

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDigestive System Surgical ProceduresSurgical Procedures, OperativeGastrectomyMyotomy

Study Officials

  • Catherine Geindre

    Assistance Publique Hôpitaux de Marseille

    STUDY DIRECTOR

Central Study Contacts

Jean-Michel Gonzalez

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2016

First Posted

October 7, 2016

Study Start

November 1, 2016

Primary Completion

September 1, 2019

Study Completion

March 1, 2020

Last Updated

October 18, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations